Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 1750 of 1949 entries
View as:
Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer
Phase: N/A
Priority: Normal
Start: 05/06/15
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 08/31/00
End: 01/31/06
Due: 01/31/07
Phase: N/A
Priority: Normal
Start: 04/17/17
End: 07/30/19
Due: 07/30/20
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 07/31/08
Due: 07/31/09
Phase: N/A
Priority: Normal
Start: 08/21/24
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 10/07/15
End: 01/29/24
Due: 01/29/25
Phase: N/A
Priority: Normal
Start: 01/18/24
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 08/31/00
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 05/21/24
Due: 05/21/25
Phase: N/A
Priority: Normal
Start: 11/06/18
End: 12/15/19
Due: 12/15/20
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 03/28/22
Due: 03/28/23
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 08/31/27
Due: 08/31/28
Phase: N/A
Priority: Normal
Start: 11/24/20
End: 11/29/22
Due: 11/29/23
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 04/30/03
End: 07/31/08
Due: 07/31/09
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 01/31/09
Due: 01/31/10
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 10/23/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 07/31/25
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 07/19/21
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 11/01/19
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/19/23
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 08/31/04
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 02/14/20
End: 01/02/25
Due: 01/02/26